| For Practicing Rheumatologists |
See all
 | Articles: Gout and Hyperuricemia |
Association of baseline disease and patient characteristics with response to etoricoxib and indomethacin for acute gout
Current Medical Research and Opinion, 08/03/07
The Impact of Gout on Work Absence and Productivity
Value in Health, 07/27/07
Reactive oxygen species and superoxide dismutases: Role in joint diseases
Joint, Bone, Spine, 07/24/07
Treatment of Acute Gout in Hospitalized Patients
Journal of Rheumatology, 07/24/07
Clinically relevant VAS pain score change in patients with acute rheumatic conditions
Joint, Bone, Spine, 07/23/07
Time required for disappearance of urate crystals from synovial fluid after successful hypouricaemic treatment relates to the duration of gout
Annals of Rheumatic Diseases, 07/18/07
Provisional guidelines for applying the Department of Health (England) 18-week-patient pathway to specialist rheumatology care
Rheumatology, 07/12/07
Cost-utility analysis of a multidisciplinary job retention vocational rehabilitation program in patients with chronic arthritis at risk of job loss
Arthritis Care and Research , 07/09/07
Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout
Rheumatology, 07/09/07
Potential use for IL-1 blockade in the treatment of gout
Clinical Practice Rheumatology, 07/05/07
|
Receive daily email updates on Gout and Hyperuricemia
|
|
Indexed Journals: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatology
more...
|
37 Available Pages
 |
 |
| Read a Different Specialty |
 |
|
|
|
 |
| Profession Index |
 |
|
|
|
 |
|
|
|
| Sponsor |
|